Project Grant G1999ONDCP03A

The U.S. Executive Office of the President Office of National Drug Control Policy (ONDCP) awarded a $2,500,000.00 Cooperative Agreement to the Legislative Analysis And Public Policy Association (LAPPA) under the Model Acts Program (CFDA 95.006). The award period is from July 1, 2023 to June 30, 2025. Under this Cooperative Agreement, LAPPA will advise states on establishing laws and policies to address illicit drug use issues. LAPPA will also revise model state drug laws and draft...

The Legislative Analysis and Public Policy Association (LAPPA) received a $1,448,275 Project Grant award from the Executive Office of the President Office of National Drug Control Policy (ONDCP) under the Model Acts Program (CFDA #95.006) to support initiatives related to the Model Acts Program from July 1, 2021 to June 30, 2023. The Model Acts Program aims to advise states on establishing laws and policies to address illicit drug use issues and revise model state drug laws and draft...

The Legislative Analysis and Public Policy Association (LAPPA) was awarded a $1,250,000 Project Grant from the Executive Office of the President Office of National Drug Control Policy (ONDCP) under the Model Acts Program (CFDA 95.006) to support initiatives related to the Model Acts Program from July 1, 2021 to June 30, 2023. The Model Acts Program aims to advise states on establishing laws and policies to address illicit drug use issues as well as revise model state drug laws and draft...

This $1.4 million cooperative agreement from the Department of Justice Office of Justice Programs Bureau of Justice Assistance will support implementation of Missouri's first statewide prescription drug monitoring program under the Harold Rogers Prescription Drug Monitoring Program. The Joint Oversight Task Force for Prescription Drug Monitoring will utilize funding to train and educate prescribers and dispensers throughout the state on processes to submit data and comply with Missouri law. This...

This $598,053 Project Grant from the Department of Justice Office of Justice Programs National Institute of Justice will fund a mixed-methods evaluation of Oregon's Measure 110 by the RAND Corporation. The goal is to analyze the implementation and effects of Measure 110, which decriminalized possession of small amounts of all drugs in Oregon. The evaluation comprises four aims: (1) analyzing Measure 110's implementation through document reviews and stakeholder interviews; (2) examining changes...

The Executive Office of the President Office of the National Drug Control Policy (ONDCP) awarded a $6 million Project Grant to All Rise For Justice (doing business as Nadcp) from October 1, 2022 to September 30, 2024. The grant supports initiatives under the Drug Court Training and Technical Assistance program (CFDA #95.005) to implement ONDCP-approved drug court training and technical assistance. Nadcp will provide drug court training and technical assistance nationwide over the two-year...

The Massachusetts Department of Public Health (MDPH) received a $1,993,123 federal Project Grant award from the U.S. Department of Justice, Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The grant funding will support two principal enhancement objectives: Development of a "buprenorphine prompt" functionality within the Massachusetts Prescription Monitoring Program (MA PMP) to alert prescribers of gaps in buprenorphine...

This $1.4 million cooperative agreement from the Department of Justice Office of Justice Programs Bureau of Justice Assistance, under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754), will fund four enforcement agents from the Ohio State Board of Pharmacy to conduct criminal investigations and analyze controlled substance prescription data from Ohio's prescription drug monitoring program (PDMP), known as the Ohio Automated Rx Reporting System (OARRS), from October 1, 2022...

This Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754) provides $1,000,000.00 to the Tennessee Department of Health to address the state's opioid overdose epidemic. The key project activities include: Integrating the state's Controlled Substance Monitoring Database (CSMD) with electronic health records to improve healthcare provider access and data sharing. 2) Analyzing controlled...

This federal Project Grant award, provided by the Department of Justice's Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754), aims to enhance the capacity of the Puerto Rico Mental Health and Anti-Addiction Services Administration (ASSMCA) to prevent prescription drug misuse and opioid-related harm across Puerto Rico. The $1,000,000 award, effective from October 1, 2024 to September 30, 2026, will support several key initiatives, including:...